Completed PHASE4 INTERVENTIONAL 2-arm NCT00994981

Magnesium Administration in Liver Transplantation and Reperfusion Injury

Does Pretreated Magnesium Protect Against Reperfusion Injury in Liver Transplanted Patients?

Sponsor: The Catholic University of Korea

Conditions Living Donor Liver Transplantation Reperfusion Injury

Updated 6 times since 2017 Last updated: Nov 27, 2011 Started: Sep 30, 2007 Primary completion: Sep 30, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Living Donor Liver Transplantation and Reperfusion Injury, this trial is completed. The trial is conducted by The Catholic University of Korea and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Catholic University of Korea

Data source: The Catholic University of Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea